Explore evidence

17.1 %The prevalence of nulliparity as a breast cancer risk factor was 17.1% among the studied women.

Kenyacancer du seinobserved 2019 and 2020published 2026JCO global oncologyPubMeddocument of 10 observations

79 scoreThe mean health-related quality of life (HRQOL) score was 79.

Kenyacancer du seinpublished 2025JCO global oncologyPubMeddocument of 5 observations

78 %Between 78% and 88% of patients across Ghana, Kenya, and Nigeria completed tests for hormone receptors and HER2.

Ghana · Kenya · Nigeriacancer du seinobserved 2014 to 2017published 2021BMJ openPubMeddocument of 13 observations

13.3 %13.3% of the participants showed signs of depression.

Kenyacancer du seinpublished 2025JCO global oncologyPubMeddocument of 5 observations

92 patients92 patients had normal (negative) findings on follow-up F-FDG PET/CT scans.

Kenyacancer du seinpublished 2024Journal of nuclear medicine : official publication, Society of Nuclear MedicinePubMeddocument of 4 observations

14 yearsThe median age at menarche among 838 pathologically confirmed breast cancer cases in Kenya was 14 years.

Kenyacancer du seinobserved between March 2012 to May 2015published 2021Breast cancer research : BCRPubMeddocument of 9 observations

9.6 %The prevalence of early menarche as a breast cancer risk factor was 9.6% among the studied women.

Kenyacancer du seinobserved 2019 and 2020published 2026JCO global oncologyPubMeddocument of 10 observations

30.7 %The prevalence of breast cancer screening among nuns in the Catholic Archdiocese of Nairobi was 30.7%.

Kenyacancer du seinpublished 2023The Pan African medical journalPubMed

5 %Among older adults, the largest rate increase over the past 20 years was observed for breast cancer with an estimated annual percentage change of 5% in each country.

Kenyacancer du seinobserved past 20 yearspublished 2019International journal of cancereurope_pmcdocument of 6 observationsDOI 10.1002/ijc.31880

20 %Only 20% of women with breast cancer admitted to inpatient hospice in Western Kenya had received surgical treatment for breast cancer.

Kenyacancer du seinobserved 2011-2019published 2022Journal of pain and symptom managementPubMeddocument of 10 observations

42.6 daysThe mean length of stay for women with breast cancer admitted to inpatient hospice in Western Kenya was 42.6 days.

Kenyacancer du seinobserved 2011-2019published 2022Journal of pain and symptom managementPubMeddocument of 10 observations

10 %Less than 10% of women with breast cancer admitted to inpatient hospice in Western Kenya voiced spiritual distress.

Kenyacancer du seinobserved 2011-2019published 2022Journal of pain and symptom managementPubMeddocument of 10 observations

98 %Pain was the predominant symptom on admission for women with breast cancer in inpatient hospice in Western Kenya, reported in 98% of cases.

Kenyacancer du seinobserved 2011-2019published 2022Journal of pain and symptom managementPubMeddocument of 10 observations

12.5 %Breast cancer is the leading cancer in Kenya, with an incidence of 12.5%.

Kenyacancer du seinpublished 2023The Pan African medical journalPubMeddocument of 14 observations

7 %The prevalence of family history of breast cancer as a breast cancer risk factor was 7.0% among the studied women.

Kenyacancer du seinobserved 2019 and 2020published 2026JCO global oncologyPubMeddocument of 10 observations

378 patientsThe final analytic sample comprised 378 female breast cancer patients with an average age of 50.

Kenyacancer du seinpublished 2023Breast cancer research and treatmentPubMeddocument of 7 observations

Breast cancer is the leading cause of cancer in sub-Saharan Africa.

Kenyacancer du seinpublished 2020International journal of cancereurope_pmcdocument of 4 observations

25 %A quarter (25%) of the participants experienced anxiety.

Kenyacancer du seinpublished 2025JCO global oncologyPubMeddocument of 5 observations

8.5 %In Nairobi, breast cancer incidence rates stabilized during 2010 to 2014 after rapidly increasing from 2003 to 2010, with an annual percent change of 8.5% (95% CI: 3.0–14.2).

Kenyacancer du seinobserved 2010 to 2014published 2020International journal of cancereurope_pmcdocument of 4 observations

22.4 %The predominant cancer types among respondents were breast cancer (22.4%), throat cancer (14.8%), prostate cancer (12.9%), bone cancer (12.5%), cervical cancer (9.9%), stomach cancer (6.0%), and skin cancer (5.1%).

Kenyacancer du seinpublished 2023Journal of oncology pharmacy practice : official publication of the International Society PubMeddocument of 8 observations

862 patientsHealth records of 862 patients with breast cancer were analysed across six tertiary care institutions in Ghana, Kenya, and Nigeria.

Ghana · Kenya · Nigeriacancer du seinobserved 2014 to 2017published 2021BMJ openPubMeddocument of 13 observations

49.2 %49.2% of the female breast cancer patients attained no or only primary-level education.

Kenyacancer du seinpublished 2023Breast cancer research and treatmentPubMeddocument of 7 observations

13 weeksThe median time from breast cancer symptom onset to presentation at Kenyatta National Hospital was 13 weeks.

Kenyacancer du seinpublished 2023Breast cancer research and treatmentPubMeddocument of 7 observations

2.03 odds_ratioCompared to patients with ER-positive tumors, ER-negative patients had an odds ratio of 2.03 for higher parity (≥5 vs ≤2 children), with 95% confidence interval (1.11, 3.72) and p = 0.021.

Kenyacancer du seinobserved between March 2012 to May 2015published 2021Breast cancer research : BCRPubMeddocument of 9 observations

62 patientsBetween 2011 and 2019, 62 women with breast cancer were admitted for care in inpatient hospice in Western Kenya.

Kenyacancer du seinobserved 2011-2019published 2022Journal of pain and symptom managementPubMeddocument of 10 observations